Houston startups named most promising in the life science space at annual event

ones to watch

Eight of the 10 most-promising life science startups named at BioHouston and the Rice Alliance's event are based in Houston. Photo courtesy of Rice Alliance

For the second time this year, Houston life science leaders and startup founders gathered to discuss the future of health care in Houston.

The annual Texas Life Science Forum hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship was usually held during the fall before the pandemic pushed it off schedule. In February, the two organizations hosted the previous forum, but as of this month, the annual event is back on track.

The day included panels and networking, plus over 50 companies — about half of which are based in Houston — pitched their solutions across medical device, therapeutics, pharmaceuticals, and more to the crowd.

Houston-based Bairitone Health won the Michael E. DeBakey Memorial Life Science Award, established by BioHouston in honor of the groundbreaking Houston cardiovascular surgeon. The company is creating a wearable technology that takes a more innovative approach to sleep apnea and snoring with its SOMNAR platform that detects tissue-born sounds, identifies obstructions, and more. The award was presented by Ann Tanabe, CEO of BioHouston.

Ann Tanabe, CEO of BioHouston, presented the DeBakey Award to Houston-based Bairitone Health. Photo courtesy of Rice Alliance

For the first time, the event also named a people's choice award winner, as voted on by the audience members. Baritone Health also claimed the prize.

At the conclusion of the event, the Rice Alliance and BioHouston named the 10 most promising life science companies selected by investors and presented by the Greater Houston Partnership. This year's selection included the following companies, in alphabetical order.

Autonomize

Austin-based Autonomizeunlocks data and context to enable human health outcomes

bEHR Health Systems

New Orleans-based bEHR Health Systemsdelivers, medical, lifestyle, and social solutions to health for African Americans.

EMPIRI

EMPIRI, based in Houston, is revolutionizing cancer care with a novel technology that accurately predicts each cancer patient's treatment responses empirically, enabling doctors to make the optimal treatment selection for each cancer patient.

InformAI

Houston-based InformAI develops AI-based medical image diagnostic tools and uses large dataset synthesis to develop clinical outcome predictors for physicians, hospitals, and medical imaging/medical device companies

March Biosciences 

Houston-based March Biosciences is impacting the most challenging lymphoma and leukemia.

MRG Health-SmartCare360

MRG Health-SmartCare360, based in Houston, is a determinate of health and disease specific virtual care management technology and services company that improves patient access to care and clinical outcomes for people suffering from one or more chronic disease.

Prana Thoracic

Prana Thoracic, founded in Houston out of JLABS at TMC, is a medical device startup that's innovating for the future of early intervention in lung cancer.

Steradian Technologies

Another med device startup based in Houston,Steradian Technologiesemploys deep-photonics technology to diagnose respiratory diseases in seconds, all for the price of a latte.

TYBR Health

Houston-based TYBR Health makes a hydrogel that protects tendons from scarring after surgery and improves patient outcomes.

Voythos

Voythos, based in Houston, is making medical records work for today's healthcare.

Check out these conferences, pitch competitions, networking, and more in the month of November. Photo via Getty Images

10+ can't-miss Houston business and innovation events for November

Where to be

Hold onto your hats, Houston. If you thought October was a busy month for business events, November even more exciting and full of pitches, conferences, summits, and more. Here's a rundown of what all to throw on your calendar for November when it comes to innovation-related events.

This article will be updated as more business and tech events are announced.

FEATURED: November 9 — Houston Innovation Awards Gala

Find out what Houston startups and innovators go home with the big win at InnovationMap and Houston Exponential's gala. Learn more about this year's finalists by clicking here.

The event is Wednesday, November 9, at 6 pm, at the Ion. Click here to register.

November 1-3 — Urban Manufacturing Alliance's Houston Gathering

Learn about the unique challenges and opportunities within manufacturing in the current economy, as well as network with Houston manufacturing professionals.

The event is Tuesday, November 1, to Wednesday, November 3, at West Houston Institute. Click here to register.

November 2 — Greentown Labs Climatetech Summit

Hear from the climatetech industry's leaders at Greentown Labs' annual event. The morning features panels and pitches, followed by lunch, networking, and an expo. The summit continues on November 3 in Boston, and both days will be streamed for viewers.

The event is Wednesday, November 2, at 8 am, at Greentown Houston and streaming online. Click here to register.

November 4 — Enventure's 10-Year Anniversary

Join Enventure as we celebrate its 10th Anniversary — from the organization's accomplishments to a look toward what the future brings to Enventure.

The event is Friday, November 4, at 7 pm, at III by Wolfgang Puck. Click here to register.

November 5 — Tech Fest Live in-person Experience at the Ion

The Ion as partnered with Tech Fest Live to bring your family to an engaging Family Tech Day experience, designed with middle and high school students in mind.

The event is Saturday, November 5, at 9:30 am, at the Ion. Click here to register.

November 8 — Texas Life Science Forum

The Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is the premier life science and healthtech event in Texas that brings together members from industry, emerging life science companies, academic and investors. Hear pitches from innovative and early stage life science companies, network and enjoy exciting panels, keynotes and speakers.

The event is Tuesday, November 8, at 8:30 am, at Rice University. Click here to register.

November 9 — The Future of Industrial Automation Lunch & Learn with Yokogawa

In this Lunch & Learn, Elbert van der Bijl (Director of Marketing & Solutions Consulting for Yokogawa North America), will talk about the journey from industrial automation to industrial autonomy (IA2IA). He will also speak about how new technologies are being embraced to be able to make this transition. The presentation will highlight some key developments like Open Process Automation (OPA), Artificial Intelligence (AI) and Machine Learning (ML), and mobile Robotics and how they will play a role in the future of Industrial Automation.

The event is Wednesday, November 9, at 11:30 am, at The Cannon-West Houston. Click here to register.

November 10 — Greater Houston Partnership's State of the Port

Join the Greater Houston Partnership at the annual State of the Port featuring Ric Campo, Chairman of the Port Commission of the Port of Houston Authority. Campo will discuss innovations taking place at Port Houston and Project 11. The highly anticipated Project 11 will deepen and widen the Houston Ship Channel and increase economic impact, jobs and address supply chain challenges.

The event is Thursday, November 10, at 10:30 am, at The Omni Riverway. Click here to register.

November 10 — BGV Pitch Tour Houston

The BGV Pitch Tour is coming to Houston November 10th in partnership with Omaze and the aid of our amazing 6 Change Agents to throw a BGV Pitch Competition. Thee BGV Change Agents are amazing Black and/or Brown women-identifying founders who are actively working to uplift and grow the city's ecosystem for Black and Brown founders in their area.

The event is Thursday, November 10, at 6 pm, at The Cannon-West Houston. Click here to register.

November 15 — Lilie's Community Celebration

Celebrate the end of the semester and take a peek into what all the Liu Idea Lab for Innovation and Entrepreneurship community has going on.

The event is Tuesday, November 15, at 6 pm, at the Lilie offices at Rice University. Click here to register.

November 17 — Rice Alliance Clean Energy Accelerator 2022 Demo Day

Rice Alliance Clean Energy Accelerator is hosting a Demo Day to showcase its Class 2 startups who are ready for investment, pilots and accelerating the energy transition.

The event is Thursday, November 17, at 1:30 pm, at the Ion. Click here to register.

November 19 — Pearland Innovation Hub Pitch Competition

Come attend this event open to the community to hear pitches from local small business owners, network, and learn about the Pearland Innovation Hub.

The event is Tuesday, November 17, at 4 pm, at Pearland City Hall. Click here to register.

November 30 — Commercial ZEV Event

This event by Houston-based Evolve is your chance to drive zero-emissions commercial vehicles and learn how you can convert your fleet to save on costs.

The event is Wednesday, November 30, at 8:30 am to 5 pm, at NRG Park. Click here to register.

Houston's medical innovation community congregated to discuss breakthrough innovations in health care. Photo via Getty Images

Houston organizations announce 10 most promising life science startups

future of health care

What startups are creating the future of health care? A Houston conference this week gathered to discuss.

The 10th annual Texas Life Science Forum hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship engaged thought leadership within the life science community with panels, discussions, and more. Additionally, 49 companies pitched their solutions across medical device, therapeutics, pharmaceuticals, and more to the crowd.

Austin-based Dynamic Light won the Michael E. DeBakey Memorial Life Science Award, established by BioHouston in honor of the groundbreaking Houston cardiovascular surgeon. The software company integrates with microscope or robotic systems to provide better visuals to surgeons and health care providers and reduce medical errors, radiation and costs. The award was presented by Ann Tanabe, CEO of BioHouston.

The event also named the 10 most promising life science companies selected by investors and presented by the Greater Houston Partnership. This year's selection included the following companies, in alphabetical order.

Ares Immunotherapy

Photo via Getty Images

Based in Cartersville, Georgia, Ares Immunotherapy uses a unique subset of T-cells for the treatment of solid tumors. According to the company, it is is preparing for a first in man trial in mesothelioma in 2023.

Corveus Medical

Photo courtesy of TMC

Houston-based Corveus Medical, which was formerly known as Caridian Medical, is a part of TMC's Biodesign program. The company was founded by Ishan Kamat, COO, and Tyler Melton, CEO.

"We are developing a novel, catheter-based device that performs a targeted sympathetic nerve ablation to treat heart failure," according to the company. "Our solution leverages the body’s natural mechanisms to bring fluid levels back to normal, giving physicians an effective treatment option, reducing costs for hospitals, and improving quality of life for the patient."

Drusolv Therapeutics

Photo via Pexels

Drusolv Therapeutics, based in Philadelphia, Pennsylvania, was founded out of Harvard University and been validated in a proof-of-concept clinical trial. The company's product, a novel reformulation of atorvastatin, is targeting age-related macular degeneration, or AMD, a serious eye disease. According to the company, it's a $4 billion a year, unmet need.

EMPIRI

Photo via jlabs.jnjinnovation.com

Houston-based EMPIRI is an early-stage biotechnology company currently focusing on precision oncology and utilizing automation for personal diagnosis. The company works out of JLABS @ TMC.

"Our proprietary 3D tissue culture method, E-slices, enables personalized drug response measurements from intact patient tissues," per the company. "E-slice has been clinically validated to accurately predict individual cancer patient responses to chemotherapies, targeted therapies, a immunotherapies."

Lapovations

Photo via Getty Images

Based in Fayetteville, Arkansas, Lapovations is working on technologies that improve laparoscopy.

"Our flagship product AbGrab is a single-use device that uses suction to lift the abdominal wall prior to closed insertion entry," according to the company. "Manually lifting can be difficult and unreliable, especially with obese patients or for clinicians with small hands."

Maxwell Biosciences

Photo by Chokniti Khongchum from Pexels

Austin-based Maxwell Biosciences is creating anti-infectives that inactivate a broad spectrum of viruses. The company's product, CLAROMERS, has seen success in its preclinical animal studies, as well as lab-grown human tissues. Maxwell is fueled by over $30 million in non-dilutive and government funding (e.g. DARPA, NIH, NIAID).

NeuraStasis

Image via neurastasis.com

Doctors have to respond quickly when treating ischemic stroke patients, and Houston-based NeuraStasis is working on a way to give them more time. Each minute a patient is waiting, irreparable damage is being done. The company's noninvasive solution uses electrical neurostimulation to preserve brain functionality. NeuraStasis is based in JLABS @ TMC.

Vena Medical

Image via venamed.ca

Canada medical device company Vena Medical is working on the "world's smallest camera" that is able to record inside veins and arteries to help physicians treat stroke.

Vivifi Medical

Photo courtesy of TMC

Houston-based Vivifi Medical, a Texas Medical Center Innovation company, is working to improve the quality of life of patients with Male Infertility and benign prostatic hyperplasia — 12 million men in the United States alone — by ending recurrency via suture-less laparoscopic technology.

XN Health

Image via xn-health.com

XN Health, based in Houston, has developed a novel approach to phrenic nerve stimulation to treat progression of ventilator induced diaphragm disfunction to help wean patients off the ventilator faster. The technology should speed up patient liberation times, shortening ICU stay, improve healthcare outcomes, and reduce health care costs.

Here's which life science companies — in Houston and beyond — are ones to watch. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

Houston organization names 10 most promising life sciences startups

ones to watch

Last week, the Rice Alliance for Technology and Entrepreneurship gathered over 1,000 life science experts and attendees virtually for thought leadership as well as 40 company presentations.

The three-day 2020 Virtual Texas Life Science Forum was made possible through a partnership with BioHouston and support from Texas Medical Center and Insperity. At the close of the summit, several companies were recognized with awards.

Houston-based Starling Medical won the Michael E. DeBakey Memorial Life Science Award, established by BioHouston in honor of the groundbreaking Houston cardiovascular surgeon. The digital health device company is revolutionizing severe bladder dysfunction management with artificial intelligence.

Every year at the forum, the Rice Alliance names its 10 most promising companies working on developing innovative solutions in medical devices, digital health, diagnostics, pharmaceuticals, and therapeutics. This year, Brad Burke, managing director of the Rice Alliance, says they had more applications to present than ever before. Additionally, the presenting companies — about half of which are Houston-based — have already raised more than $275 million in funding.

The 2020 most-promising life science companies, which were chosen by investors and presented by the Greater Houston Partnership, were:

Droice Labs

Image via droicelabs.com

New York-based Droice Labs, is an artificial intelligence and big data company matches patients to therapies and delivers personalized medicine at scale while reducing costs.

"Our cutting-edge technology seamlessly integrates into clinical workflows, and we continue to evolve unique and powerful applications for our clients and the patients they serve," reads the company's website.

SFA Therapeutics

Image via sfatherapeutics.com

Based in Jenkintown, Pennsylvania, SFA Therapeutics is developing oral drugs for treating conditions of chronic inflammation that have the potential to change the practice of medicine. The company has treatments for Psoriasis, Liver Cancer (Hepatitis B, NASH and HCC), Ophthalmic Diseases, Cytokine Release Syndrome- a side effect in CAR-T, Prevention of Relapse/Recurrence in Leukemias, and other diseases.

Hummingbird Bioscience

Photo via jlabs.jnjinnovation.com

Hummingbird Bioscience, based in Houston's JLABS @ TMC, is tackling challenging targets that play a key role in disease yet have not been effectively drugged. The company has worked on 12 therapies in various stages of development, four of which have the potential to revolutionize their fields.

"At Hummingbird, we believe that modern approaches to systems biology and data science can overcome the challenges of classical methods of therapeutics discovery, and profoundly improve the way we deliver new transformative medicines," reads the company website.

CaseCTRL

Image via casectrl.com

Houston-based CaseCTRL is empowering surgeons with a management platform with software-as-a-service technology that uses AI and logistics to lower operational costs and simplify surgical planning.

"The surgical scheduling process is frustratingly stuck in the past: siloed, paper-based, and too dependent on single schedulers," reads the website. "Surgeons are stressed and overworked. They need a better way to communicate their complex surgical plans, timelines and resource needs."

Perimeter Medical

Image via perimetermed.com

Perimeter Medical, based in Dallas, is driven to transform cancer surgery with advanced, real-time, ultra high-resolution imaging tools including AI to address areas of unmet medical need.

"Perimeter is dedicated to providing solutions that drive better patient care and lower healthcare costs by providing critical information, during clinical procedures," reads the website.

Studio Bahria

Image via studiobahia.org

San Antonio-based Studio Bahia, is developing an accessible model for therapy in addressing mental health crises from the pandemic through virtual reality.

"We are in production of our first two therapies for release in the 4th quarter of 2020. Studio Bahia clients include corporate, retail, and institutional partners who purchase our headsets for $25 in providing mental health therapies and wellness tools to employees, executives, and patients," reads the company's website.

Tvardi Therapeutics

Photo via Getty Images

Tvardi Therapeutics, based in Houston, is a clinical-stage biopharmaceutical company focused on the development of a new class of breakthrough medicines for diverse cancers and chronic inflammatory and fibrotic diseases.

"Tvardi is focused on the development of orally delivered, small molecule inhibitors of STAT3, a key signaling molecule positioned at the intersection of many disease pathways," reads the website.

Koda Health

Image via kodahealthcare.com

Koda Health, Houston, uses AI to help guide difficult conversations in health care, starting with end-of-life care planning.

"You're entitled to protect the healthcare decisions that matter most to you and your family," the company's website promises. "Koda creates Care Plans to ensure that you get the medical care you want."

Immuno Genesis

Photo via Getty Images

Houston-based ImmunoGenesis is a clinical-stage biotechnology company developing therapeutics to catalyze effective immune responses in immunologically "cold" cancers such as prostate, colorectal, and pancreatic.

"Compared to existing immunotherapy drugs, we believe this antibody will both provide more consistent benefit for patients with immune-infiltrated tumors, and, for the first time, will also benefit patients with immune 'cold' cancers," says founder Dr. Michael A. Curran in a press release announcing the company's grant from the Cancer Prevention and Research Institute of Texas.

Ictero Medical

Image via Getty Images

Ictero Medical, based in Houston, is developing the first minimally invasive cryoablation solution to treat patients with gallstone disease. Ictero Medical has created a minimally invasive treatment, called The CholeSafe System, that uses cryoablation to defunctionize the gallbladder without having to remove it.

Here's what life science startups were named most promising at the recent Rice Alliance Texas Life Science Forum.. Getty Images

Rice Alliance names most promising life science companies at annual forum

Best of the best

Houston hosted an annual meeting of the minds that included thoughtful discussions, presentations, panels, and startup pitches within the life science industry.

The Texas Life Science Forum, organized and hosted by the Rice Alliance and BioHouston, took place on November 6 at Rice University's Bioscience Research Collaborative. Throughout the day, over 50 life science startups pitched to the audience. At the end of the forum, 10 startups — most of which are based in Houston — were recognized as being the most promising.

Here's what life science startups you should be keeping an eye out for.

Abilitech Medical

abilitech

Photo via abilitechmedical.com

A St. Paul, Minnisota-based medical device company, Abilitech Medical develops assistive technology to Multiple sclerosis, Muscular Dystrophy, Parkinson's and stroke patients. The first product, Alibitech Assist, will be cleared by the FDA in 2020, with other devices to follow in 2022 and 2023.

AgilVax

agilvax

Photo via agilvax.com

Based in Albuquerque, New Mexico, AgilVax is a biopharmaceutical company that works with chemotherapy, checkpoint and KRAS inhibitors to fight various cancers. The company's AX09 is an immunotherapeutic that is headed for human clinical trials in 2020. Another product, M5, is a monoclonal antibody currently in preclinical trials.

Altoida

altoida

Photo via altoida.com

Altoida, based in Houston, has created a medical device that uses artificial intelligence and augmented reality to collect functional and cognitive data in patients to determine their risk Mild Cognitive Impairment from Alzheimer's Disease. The Altoida Neuro Motor Index has been cleared by the FDA and CE and detects cognitive decline with a 94 percent diagnostic accuracy six to 10 years ahead of the onset of symptoms.

ColubrisMX

Photo via Pexels

Houston-based ColubrisMX makes surgical robots specializing in minimally invasive and endoluminal surgeries. The company's team of engineers and surgeons works adjacent to the Texas Medical Center.

Cord Blood Plus

stem cell

Photo via Getty Images

Cord Blood Plus, based in Galveston, is working to commercialize its human umbilical cord blood stem cell technology. The company's primary mission is to use its research and treatment on breast cancer patients undergoing chemotherapy in order to prevent infections, speed up recovery, and shorten hospital stays.

CorInnova

CorInnova

Photo via CorInnova.com

Another Houston company, CorInnova is a medical device company that has developed a cardiac assist device to treat heart failure without many of the consequences from standard treatment. The device is able to self expand and gently compress the heart in sync with the heartbeat.

Mesogen

mesogen

Photo via Mesogen.com

Mesogen, which is based in The Woodlands, is in the business of using a patient's own cells to grow a human kidney for transplant. The tissue engineering technology allows for the creation of a kidney in less than a year with less risk of transplant rejection and a better quality of life over dialysis treatment.

Saranas

Courtesy of Saranas

Houston-based Saranas has created its Early Bird device to more quickly and more accurately detect bleeding in the human body. The company, which underwent successful clinical trials last year, recently received FDA clearance and launched the device in the United States.

Stream Biomedical

stream biomedical

Photo via streambiomedical.com

Stream Biomedical Inc. is tapping into a therapeutic protein that has proven to be neuroprotective and neuroreparative. The Houston company is aiming to apply the treatment in acute stroke cases and later for traumatic brain injury, Alzheimer's, and dementia cases.

VenoStent

Photo via venostent.com

Houston-based VenoStent has created a device that allows a successful stent implementation on the first try. VenoStent's SelfWrap is made from a shape-memory polymer that uses body heat to mold the stent into the vein-artery junction.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

University of Houston team places in prestigious DOE collegiate challenge

seeing green

A team of students from the University of Houston have placed in the top three teams for a national competition for the Department of Energy.

The inaugural American-Made Carbon Management Collegiate Competition, hosted by the U.S. Department of Energy's Office of Fossil Energy and Carbon Management, or FECM, tasked the student teams with "proposing regional carbon networks capable of transporting at least one million metric tons of carbon dioxide per year from industrial sources," according to a news release from DOE.

“With this competition, DOE hopes to inspire the next generation of carbon management professionals to develop carbon dioxide transport infrastructure that will help drive technological innovation and emissions reductions, new regional economic development, and high-wage employment for communities across the United States,” Brad Crabtree, assistant secretary of fossil energy and carbon management at DOE, says in the release.

GreenHouston, the University of Houston team mentored by Assistant Professor Jian Shi from the UH Cullen College of Engineering, took third place in the competition, securing a $5,000 cash prize. Sequestration Squad of University of Michigan secured first place and $12,000 and Biggest Little Lithium of the University of Nevada won second and a $8,000 prize.

The UH team's proposal was for an optimized carbon dioxide transportation pipeline for the Houston area. The presentation included cost analysis, revenue potential, safety considerations, weather hazards, and social impact on neighboring communities, according to a release from UH.

“We chose the greater Houston metropolitan area as our target transition area because it is a global hub of the hydrocarbon energy industry,” says Fatemeh Kalantari, team leader, in the release.

“Our team was committed to delivering an optimized and cost-effective carbon dioxide transfer plan in the Houston area, with a focus on safety, environmental justice, and social engagement,” she continues. “Our goal is to ensure the health and safety of the diverse population residing in Houston by mitigating the harmful effects of carbon dioxide emissions from refineries and industries in the area, thus avoiding environmental toxicity.”

With the third place win, GreenHouston will get to present their proposal at DOE’s annual Carbon Management Research Project Review Meeting slated for August.

"We are thrilled to see the exceptional work and dedication displayed by the GreenHouston team in this competition," said Ramanan Krishnamoorti, vice president of energy and innovation at UH. "The team’s innovative proposal exemplifies UH’s commitment to addressing the pressing global issue of carbon management and advancing sustainable practices. We wish the students continued success."

The team included four Cullen College of Engineering doctoral students from the Department of Electrical and Computer Engineering – Kalantari, Massiagbe Diabate, Steven Chen, and Simon Peter Nsah Abongmbo – and one student, Bethel O. Mbakaogu, pursuing his master’s degree in supply chain and logistics technology.

The prize money will go toward funding additional research, refining existing technologies, addressing remaining challenges and raising awareness of CCUS and its project, according to the release, as the team feels a responsibility to continue to work on the GreenHouston project.

“The energy landscape by 2050 will be characterized by reduced greenhouse gas emissions, cleaner air quality, and a more sustainable environment,” Kalantari says. “The transition to green energy will not only mitigate the harmful effects of carbon dioxide on climate change but also create new jobs, promote economic growth, and enhance energy security. This is important, and we want to be part of it.”

The team of students plans to continue to work on the GreenHouston project.

Houston college to launch new smart building degree-program in the fall

coming soon

Houston Community College will launch a new 60-hour Smart Building Technology program this fall, the college announced last week.

The program will train students on the installation of low-voltage controls, such as audio/visual systems, energy management, lighting controls, security cameras, burglar and fire alarm systems, retail and grocery store automation, medical automation and more, according to HCC. Students will receive an Associate of Applied Science degree after completing the program.

“This program is both cutting edge and down to earth,” Matt Adams, instructor and program coordinator for HCC’s Electrical Technology program, said in a statement.

"A lot of new technology is coming into this industry, but a lot of the technology is the same as it has been for the last five to 10 years," he went on to add. "What is new is the integration of it all, making it all work together, to make people’s lives better.”

The Smart Building Technology program will be part of HCC Central’s Electrical Technology program in the Architectural Design and Construction Center of Excellence (COE). According to the college, it's one of the first programs of its kind.

Adams says that the earning potential in this line of work starts at around $50,000 a year, with the potential to earn double that with additional learning and training.

In late 2022, HCC and partners also received a $1.8 million grant from JP Morgan Chase to launch a new certificate program to help residents who come from some of Houston’s most underserved and under-resourced neighborhoods find career opportunities in the clean energy, disaster response, utilities, trades and manufacturing fields. Partnering employers included The City of Houston, Harris County and TRIO Electric.

Meanwhile, Houston Methodist and Texas A&M University graduated the inaugural class from its School of Engineering Medicine earlier this month.

Graphic courtesy of HCC

Houston expert: How technology can be used to bridge the health equity gap

guest column

Progressively over the last decade, the health care industry has become increasingly aware of the role that social determinants of health play in the health outcomes of patients.

Social determinants of health, or SDOH, are the conditions in which people are born, grow, live, work, and age, and they have a significant impact on a person's health and well-being. Examples of SDOH include income, education level, housing, and access to healthy food.

One of the key challenges facing health care organizations and providers is how to address health equity gaps, which are the differences in health outcomes between different populations. Health equity gaps are often caused by social determinants of health, and they can be particularly pronounced among vulnerable populations such as low-income communities, racial and ethnic minorities, and those living in rural areas.

Experience management technology has emerged as a powerful tool for addressing these equity gaps. This technology uses feedback, behaviors, and other relevant SDOH data in order to understand the unique needs of different populations and develop targeted interventions to improve their health outcomes.

One of the key ways that experience management technology can help decrease health equity gaps is by segmenting populations by social determinants of health. By collecting data on patients' demographics, such as their age, race, income, and education level, health care organizations can gain a better understanding of the SDOH that are most relevant to each population. This information can be used to develop personalized actions that address the specific needs of each population, rather than relying on a one-size-fits-all approach.

For example, health care organizations could use experience management technology to gather feedback from patients on their access to healthy food. By segmenting the patient population by zip code, health care organizations could identify patients in rural areas who do not have easy access to quality care facilities and providers. These patients could then be targeted with interventions such as transportation assistance programs or care coordination programs, which could help address their specific needs.

In addition to segmenting populations by social determinants of health, experience management technology can also help health care organizations gather insights into patient behaviors. By integrating data on patients' health behaviors, such as adherence to treatment or missed appointments, health care organizations can develop targeted interventions that encourage healthy behaviors.

For example, health care providers could use experience management technology to collect data on patients' treatment habits. Patients who report low adherence to treatment could be targeted with interventions such as treatment education programs or care coaching, which could help them develop healthier habits over time.

Finally, experience management technology can help health care organizations gain insight into their patient’s end to end journey. By integrating data from multiple sources, such as electronic health records, patient feedback, and social determinants of health data, health care organizations can develop a more comprehensive understanding of patients' health needs and brand expectations. This unified illustration allows health care organizations to improve business outcomes such as lower readmission rates, and create loyal patients that will refer their friends and family in the most important and sensitive moments in their lives.

In conclusion, experience management technology has emerged as a powerful tool for addressing health equity gaps by segmenting populations by social determinants of health, understanding and acting on their unique needs through feedback, behaviors, and dynamic integrations. By leveraging this technology, health care organizations can develop unique solutions that improve the health outcomes of vulnerable populations, such as low-income communities, racial and ethnic minorities, and those living in rural areas.

As the health care industry continues to evolve, experience management technology will play an increasingly important role in addressing health equity gaps and improving the health and well-being of patients across the globe.

------

Ariel Jones is the head of health care provider solution strategy for Qualtrics XM, an American Experience Management company providing software solutions for customer and employee experience.

View All Listings